News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Semaphorin and neuropilin co-expression in motoneuronssets axon sensitivity to environmental semaphorin sources during motor axon pathfinding
Areas: Neurology, Signalling
Overexpression of Semaphorin 3A (Sema3A) causes defasciculation and excessive growth of motor axons into normally non-permissive territories, as a study conducted by scientist from the University of Lyon in France concludes. They also state that motoneuronal Sema3A is required for correct spinal nerve compaction and dorsal motor axon extension.
Class 3 semaphorins are intercellular guiding cues for migrating cells and axons, secreted by the surrounding tissues in the developing organism. They are essential for the formation of nerves and vasculature. The scientists observed Sema3A expression in motoneurons during spinal nerve development. The study uncovered how the growth cone's level of sensitivity to exogenous Sema3A exposure is influenced by Sema3A expression in motoneurons. This regulation is linked to the availability of the Sema3A receptor neuropilin 1 at the growth cone surface.
Apparently, Sema3A in motoneurons enables them to grow more or less far away from the repulsive signals given by exogenous Sema3A. This interplay between intrinsic and extrinsic Sema3A seems to be an important factor in the accurate specification of axon pathways.
Related antibodies on antibodies-online.com:
Antibodies for the research area neurology: »Show antibodies
Antibodies for the research area signalling: »Show antibodies
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011

